Healthtech Startups
18,755 companies tagged Healthtech, with their investors and founders.
0 investors
JSK Therapeutics is a privately held drug development company working on pharmaceutical products, with funding tied to cancer-related research grants. It has received awards from the National Cancer Institute and backing from seed funds, state technology boards, and angel investors.
0 investors
0 investors
JucaBio is a privately held, clinical-stage biopharmaceutical company using a hub-and-spoke model to acquire differentiated drug assets and build subsidiaries that run focused clinical development programs. It targets drugs addressing significant unmet medical needs.
0 investors
0 investors
Jump Technologies provides JumpStock, a cloud-based, mobile point-of-use system for hospitals to track and manage medical supplies from the loading dock to patient consumption, reducing overstock and preventing stock outs. Its software integrates with existing EHR and ERP systems via APIs to give clinicians and supply chain staff shared inventory data and analytics.
0 investors
Juniper Health provides software that automates trauma registry data abstraction by pulling data from EHRs, applying registry logic, and using NLP to extract details from physician notes. It is built for trauma program managers and registrars at hospitals and health systems to reduce abstraction time and improve data quality and completeness.
0 investors
0 investors
Jupiter Biomedical Research is a drug development company with patents for two therapeutic candidates: JBR-102, an oral treatment for glioblastoma multiforme and other brain tumors, and JBR-201, an antiviral treatment for measles virus infections and related neurological diseases. The company is pursuing regulatory approval from Health Canada and the FDA for its lead cancer candidate while advancing preclinical development of its antiviral program.
0 investors
Jupiter Neurosciences develops JOTROL, an enhanced resveratrol formulation designed to address neuroinflammatory and central nervous system disorders, with a Phase IIa trial underway in Parkinson's Disease, while also selling wellness supplements under the Nugevia brand through direct-to-consumer channels.
0 investors
0 investors
0 investors
0 investors
Jyzen offers personalized integrative medicine and wellness programs focused on healthy aging, longevity, chronic disease resolution, cognitive function, and performance optimization. It combines medical providers with fitness and wellness practitioners, using a diagnostics, detox, optimization, and maintenance process to deliver individualized care.
0 investors
K Medical is a healthcare startup developing simple, effective medical solutions, with a current focus on preventing bedsores (pressure ulcers). The company's work is supported by NIH STTR and SBIR grants and conducted in collaboration with academic experts in compliant mechanisms and assistive technologies.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Kamal Therapeutics is developing an intravenous recombinant human decorin as a treatment for dystrophic epidermolysis bullosa. It operates as a biotechnology company focused on therapeutics for this genetic skin disorder.
0 investors
0 investors
0 investors




